Cipher Pharmaceuticals Stock Price on July 4, 2025
| CPH Stock | CAD 12.17 0.12 1.00% |
If you're considering investing in Cipher Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cipher Pharmaceuticals stands at 12.17, as last reported on the 4th of August, with the highest price reaching 12.56 and the lowest price hitting 11.98 during the day. Cipher Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.12, which signifies that the company had a -0.12 % return per unit of risk over the last 3 months. Cipher Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cipher Pharmaceuticals' Standard Deviation of 2.2, mean deviation of 1.59, and Risk Adjusted Performance of (0.04) to double-check the risk estimate we provide.
At this time, Cipher Pharmaceuticals' Total Stockholder Equity is very stable compared to the past year. As of the 4th of August 2025, Common Stock Shares Outstanding is likely to grow to about 31.9 M, though Other Stockholder Equity is likely to grow to (9 M). . At this time, Cipher Pharmaceuticals' Price Fair Value is very stable compared to the past year. Cipher Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cipher |
Price Book 2.1429 | Enterprise Value Ebitda 19 | Price Sales 7.8915 | Shares Float 5.2 M | Wall Street Target Price 15.775 |
Cipher Pharmaceuticals Valuation on July 4, 2025
It is possible to determine the worth of Cipher Pharmaceuticals on a given historical date. On July 4, 2025 Cipher was worth 13.43 at the beginning of the trading date compared to the closed value of 13.57. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cipher Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Cipher Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cipher Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cipher Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 12.83 | 13.44 | 12.73 | 13.34 | 59,806 | |
07/04/2025 | 13.43 | 13.66 | 13.38 | 13.57 | 6,853 |
| 13.50 | 13.50 | 13.11 | 13.29 | 23,932 |
| Backtest Cipher Pharmaceuticals | | | Cipher Pharmaceuticals History | | | Cipher Pharmaceuticals Valuation | Previous | Next |
Cipher Pharmaceuticals Trading Date Momentum on July 4, 2025
| On July 07 2025 Cipher Pharmaceuticals was traded for 13.29 at the closing time. The maximum traded price for the trading interval was 13.50 and the lowest daily price was 13.11 . The daily volume was recorded at 23.9 K. The volume of trading on 7th of July 2025 played a part in the next trading day price drop. The overall trading delta to the next closing price was 2.06% . The overall trading delta to the closing price today is 3.91% . |
Cipher Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Cipher Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cipher Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cipher financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cipher Pharmaceuticals Stock history
Cipher Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cipher is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cipher Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cipher Pharmaceuticals stock prices may prove useful in developing a viable investing in Cipher Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.6 M | 31.9 M | |
| Net Income Applicable To Common Shares | 11.5 M | 7.8 M |
Cipher Pharmaceuticals Quarterly Net Working Capital |
|
Cipher Pharmaceuticals Stock Technical Analysis
Cipher Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cipher Pharmaceuticals Period Price Range
Low | August 4, 2025
| High |
0.00 | 0.00 |
Cipher Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cipher Pharmaceuticals August 4, 2025 Market Strength
Market strength indicators help investors to evaluate how Cipher Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cipher Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cipher Pharmaceuticals stock market strength indicators, traders can identify Cipher Pharmaceuticals entry and exit signals to maximize returns
Cipher Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cipher Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cipher Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cipher to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.13) | |||
| Total Risk Alpha | (0.43) | |||
| Treynor Ratio | 1.1 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.